MARATTO

article · Health Science Reports

Exploring Glucagon‐Like Peptide‐1 Receptor Agonists Usage Among Non‐Diabetic Healthcare Providers: A Cross‐Sectional Multi‐Country Study

20254 citationsOpen accessAlexandria University

Abstract

This study provides the first prevalence estimate of GLP-1RA use among HCPs and GLP1-Ras users and explores the associations between demographic characteristics and perceptions of safety and efficacy. The findings highlight the self-prescribing practices of these medications for weight management and underscore the need for appropriate monitoring to avoid potential health risks.

Research topics

  • Diabetes Treatment and Management
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmacology and Obesity Treatment

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/hsr2.70638

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.